Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to detect circulating tumor DNA can predict lung cancer outcome in a Cancer Research UK-funded study.
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an ...
As President and CEO, Dr. Ramos will oversee The Lundquist Institute’s expansive research portfolio, which includes over 600 active studies led by 100 principal investigators. TLI’s multidisciplinary ...
Jan. 10, 2025 — A study shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer. Investigators examined how molecular dynamics at the ...
The USF Institute for Nonviolence and Social Justice investigates, illuminates, and advances the theory and practice of transformational nonviolence to confront and overcome injustice and systemic ...